Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
322 Leser
Artikel bewerten:
(2)

Evident: EVIDENT Launches Sixth Annual Image of the Year Contest

Evident-IOTY Header

Image Attribution, from left to right: Cross-section of a Cosmic Orange aster flower with pollen grains maturing inside anthers. Captured by Igor Siwanowicz of the United States 2024. Nervous system of a juvenile sea star (Patiria miniata) about 1 cm wide. Captured by Laurent Formery of the United States 2022. Arabidopsis thaliana flower with pollen tubes growing through the pistil. Captured by Jan Martinek of Czech Republic 2021.

WALTHAM, Mass., Oct. 09, 2025. Winners will be selected by a jury and announced in spring 2026.

Contest Details
The global prize and three regional prizes will be awarded to the scientific images that receive the highest scores. The grand prize for the global winner is an Evident SZX7 stereo microscopewith a DP23 digital cameraor Evident UPLXAPO Objectives. Prizes also include an Evident CX23 upright microscopeor SZ61 stereo microscopefor the regional winners in Asia, Europe, and the Americas. An additional prize of an SZ61 stereo microscopewill be awarded to the winner of a dedicated category for materials science and engineering images.

The international jury consists of experts in science and imaging. Returning from last year are Geoff Williams, manager of the Leduc Bioimaging Facility at Brown University; Harini Sreenivasappa, microscopy facility manager of the Cell Imaging Center at Drexel University; and Wen-Tai Chiu, professor in the Department of Biomedical Engineering at National Cheng Kung University. New to the jury are Eliska Macickova, light microscopy application specialist at the University of Zurich; Ben Dubin-Thaler, founder and executive director of BioBus; and Jung Weon Lee, professor in the Department of Pharmacy at Seoul National University. All entries will be evaluated based on artistic and visual aspects, scientific impact and microscope proficiency.

Full contest terms and conditions can be found at Evidentscientific.com/en/landing/ioty-six-annual.

About the Image of the Year Award
Evident's Image of the Year Award began in 2017 as the Image of the Year European Life Science Light Microscopy Award with the aim to celebrate both the artistic and scientific value of microscopy images. Today, the competition stays true to this mission by encouraging people around the world to look at scientific images in a new way, appreciate their beauty, and share images with others.

To learn more about our past award-winning images and the microscope techniques used to capture them, visit Evidentscientific.com/en/ioty-gallery.

About EVIDENT
For over 100 years as Olympus, we set the industry standard for optical precision in microscopy, helping the world see what was once out of view. Today, as Evident, we continue to help scientists, physicians, and engineers illuminate the unseen with advanced imaging solutions that combine renowned optics with cutting-edge digital innovation.

Our life science portfolio supports research, clinical diagnostics, and education, offering a comprehensive range of imaging methods from essential brightfield and darkfield microscopy to advanced fluorescence, 4D analysis, and digital pathology. In industrial microscopy, we deliver precision and flexibility through laser scanning, digital, and semiconductor microscopes designed for tasks ranging from routine inspection to intricate quality control and manufacturing analysis.

Whether advancing new therapies, ensuring product integrity, or exploring the unknown, Evident is defining a new era of discovery with easy-to-use tools that help unlock hidden answers and empower exciting new breakthroughs.

Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China, with operations and dedicated sales and service centers around the world. For more information, visit EvidentScientific.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f643a70c-ae8c-4166-aae5-3772ab6cb0ce



Media Contact: Michelle Gaynor michelle.gaynor.ext@evidentscientific.com +1 609 828 3634

© 2025 GlobeNewswire (Europe)
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.